Trial
NCT04906876
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Brown University
Collaborators
Actuate Therapeutics Inc.
Condition
Sarcoma
Intervention
Gemcitabine
Why stopped
IND withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-28